A microcapsule powder composition containing Acer truncatum seed oil, and preparation method and application thereof
By combining Yuanbao maple seed oil with Chinese herbal medicines such as Gastrodia elata, Pueraria root, ginseng, Poria, lily, Angelica sinensis and other Chinese herbal materials in a specific proportion, the problem of poor treatment of Yuanbao maple seed oil in Alzheimer's disease is solved. , significantly improved multiple indicators in Alzheimer's mice, achieving better therapeutic effects and drug stability.
Patent Information
- Application Number
- CN202410895248.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-05
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-07-05
AI Technical Summary
The existing Yuanbao Maple Seed Oil Microcapsule Powder is not effective enough in the treatment of Alzheimer's disease and is difficult to be used in industrial application. Moreover, the therapeutic effects of traditional Chinese medicine prescriptions vary greatly, and the clinical application experience and effect are not good.
Microcapsule powder composition containing Yuanbao maple seed oil is used to make microcapsule powder by combining Yuanbao maple seed oil with Chinese herbal medicines such as Gastrodia elata, Pueraria root, ginseng, Poria cocos, lily, Angelica sinensis and other Chinese herbal materials in a specific proportion, and emulsification and wall materials are used. Embedding technology improves stability and absorption rate, and obtains Chinese medicine extracts through water and alcohol extraction to form Chinese medicine microcapsules powder, and prepares them in combination with lecithin and maltodextrin.
Significantly improved hippocampus and cortical atrophy, spatial learning, memory ability, cognitive dysfunction, antioxidant ability and intestinal flora diversity in Alzheimer's mouse model, improved therapeutic effect, and enhanced drug stability Sex and absorption rate simplify the way of taking and reduce side effects.
Smart Images

Figure CN118416168B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of biomedicine and relates to a microcapsule powder composition containing Acer truncatum seed oil and a preparation method and application thereof. Background Art
[0002] Alzheimer's disease is an irreversible neurodegenerative disease caused by multiple reasons. It is the most common type of dementia. Its onset is closely related to age, genetic factors and environmental factors. However, the etiology and pathogenesis of the disease have not been fully studied so far. Its pathological characteristics are mainly extracellular neuritic plaques formed by the accumulation of amyloid-β in the cerebral cortex and hippocampus, and neurofibrillary tangles in nerve cells formed by hyperphosphorylation of Tau protein. In addition, neuroinflammation, oxidative stress, cellular autophagy disorders, brain-gut-microbe axis and metabolic disorders are also important characteristics of Alzheimer's disease. More and more studies have shown that intestinal flora can affect the structure and function of the brain and host behavior through the gut-brain axis, and it plays a vital role in maintaining the healthy homeostasis of the body. Alzheimer's disease is an extremely complex disease. Currently, the FDA has approved only four drugs for the treatment of Alzheimer's disease: rivastigmine, galantamine, donepezil and memantine, all of which are cholinesterase inhibitors and memantine targets NMDA receptors. The efficacy of these drugs is very limited, and long-term use will also lead to a series of side effects. Therefore, finding potential natural drugs that can effectively prevent and treat Alzheimer's disease is a key scientific issue that needs to be addressed urgently.
[0003] Patent CN105816491A discloses a method for preparing an oral liquid of Acer truncatum seed oil, which mentions that the Acer truncatum seed oil is processed by microcapsule embedding, has the characteristics of high content of vitamins and neuraminic acid, and can be used to promote children's brain development, improve intelligence, inhibit Alzheimer's disease and Parkinson's disease, and improve sequelae of cerebral stroke; but it does not disclose what effect the Acer truncatum seed oil has when used for Alzheimer's disease. Making Acer truncatum seed oil into Acer truncatum seed oil microcapsule powder solves the problem that Acer truncatum seed oil has poor stability, is easy to oxidize and deteriorate, and affects its quality and efficacy to a certain extent, but making Acer truncatum seed oil microcapsule powder into Alzheimer's disease drugs is difficult to be industrialized in practice because its effect is not prominent enough. Summary of the invention
[0004] The purpose of the present invention is to solve the problem that in practice, it is difficult to industrialize the preparation of Acer truncatum seed oil or Acer truncatum seed oil microcapsule powder into an Alzheimer's disease drug because its effect is not prominent enough.
[0005] Based on the above purpose, the present invention solves this need in the field by providing a microcapsule powder composition containing Acer truncatum seed oil and a preparation method and application thereof.
[0006] Although the improvement effects of some specific Chinese medicine combinations on Alzheimer's disease have been reported, there are differences in the therapeutic effects of different formulations. At the same time, how to improve the clinical application experience and therapeutic effect of Chinese medicine formulations is also one of the technical difficulties of the present invention.
[0007] The present invention provides a Chinese medicine compatibility prescription based on the experimental results of the inventors in the early stage, which specifically includes the following Chinese medicine ingredients: Gastrodia elata, Pueraria lobata, ginseng, Poria cocos, Lilium bulbus and Angelica sinensis. Gastrodia elata, Pueraria lobata, ginseng, Poria cocos, Lilium bulbus and Angelica sinensis are six kinds of medicinal materials commonly used in traditional Chinese medicine, and each of them has different effects and functions, such as Gastrodia elata can calm the liver and extinguish wind, Pueraria lobata can induce sweating and relieve the symptoms, Ginseng can replenish qi and produce body fluid, Poria cocos can promote diuresis and eliminate dampness, Lilium bulbus can nourish yin and moisten the lungs, and Angelica sinensis can activate blood circulation and regulate menstruation. These medicinal materials have an important position in the theory and practice of traditional Chinese medicine, but their use also has certain restrictions and precautions, such as compatibility.
[0008] On the one hand, the present invention relates to a microcapsule powder composition containing Acer truncatum seed oil, which is composed of Acer truncatum seed oil microcapsule powder and Chinese medicine microcapsule powder;
[0009] In parts by weight, the Chinese medicinal raw materials in the Chinese medicinal microcapsule powder are composed of 6-9 parts of Gastrodia elata, 8-10 parts of Pueraria root, 5-8 parts of ginseng, 5-9 parts of Poria cocos, 5-9 parts of lily, and 6-9 parts of Angelica sinensis.
[0010] Based on the common knowledge of technicians in this field, the composition and ratio of the Chinese medicine raw materials in the Chinese medicine microcapsule powder are obtained by the inventors after a large number of preliminary screening tests, and should not be increased, decreased or adjusted to avoid reduction or loss of efficacy and avoid additional side effects.
[0011] Furthermore, in the microcapsule powder composition containing Acer truncatum seed oil provided by the present invention, the ratio of the Acer truncatum seed oil microcapsule powder to the traditional Chinese medicine microcapsule powder is (4-8):6 by mass ratio; preferably, the ratio of the Acer truncatum seed oil microcapsule powder to the traditional Chinese medicine microcapsule powder is 4:6 by mass ratio.
[0012] Preferably, in parts by weight, the Chinese medicinal raw materials in the Chinese medicinal microcapsule powder are composed of 6 parts of Gastrodia elata, 8 parts of Pueraria root, 5 parts of ginseng, 5 parts of Poria cocos, 5 parts of lily, and 6 parts of Angelica sinensis.
[0013] On the other hand, the present invention relates to a method for preparing the microcapsule powder composition containing Acer truncatum seed oil, which comprises: emulsifying the Acer truncatum seed oil and embedding it with a wall material to prepare the Acer truncatum seed oil microcapsule powder;
[0014] The Chinese medicine raw material is extracted with water and / or alcohol and then concentrated to obtain a Chinese medicine extract. The Chinese medicine extract is mixed with water and embedded with a wall material to obtain the Chinese medicine microcapsule powder.
[0015] Furthermore, in the method for preparing the microcapsule powder composition containing Acer truncatum seed oil provided by the present invention, the emulsifier used for emulsification is lecithin;
[0016] The wall material used in the Acer truncatum seed oil microcapsule powder and / or the Chinese medicine microcapsule powder is maltodextrin.
[0017] Furthermore, in the preparation method of the microcapsule powder composition containing Acer truncatum seed oil provided by the present invention, the traditional Chinese medicine extract is mixed with water in a ratio of 10-30 g:100 mL.
[0018] On the other hand, the present invention relates to the use of the microcapsule powder composition containing Acer truncatum seed oil in the preparation of Alzheimer's disease drugs, wherein the microcapsule powder composition containing Acer truncatum seed oil improves at least one of the following: hippocampus and cortical atrophy, spatial learning, memory ability, cognitive dysfunction, antioxidant ability, and intestinal flora diversity.
[0019] Furthermore, in the application provided by the present invention, the particle size of the Acer truncatum seed oil microcapsule powder is 10-40 μm, and the particle size of the traditional Chinese medicine microcapsule powder is 3-11 μm.
[0020] Preferably, the particle size of the Acer truncatum seed oil microcapsule powder is 10-20 μm, and the particle size of the traditional Chinese medicine microcapsule powder is 3-7 μm.
[0021] Based on the contents of the present invention, it is easy for a person skilled in the art to know that, although the present invention provides a microcapsule powder of Acer truncatum seed oil and a microcapsule powder of Chinese medicine, the purpose of making the Acer truncatum seed oil or the Chinese medicine raw material into microcapsule powder is to give full play to the medicinal properties, and it does not affect the pharmacology of the Acer truncatum seed oil or the Chinese medicine raw material. According to the test, when the Chinese medicine raw material is composed of 6-9 parts of Gastrodia elata, 8-10 parts of Pueraria root, 5-8 parts of Ginseng, 5-9 parts of Poria cocos, 5-9 parts of Lilium, and 6-9 parts of Angelica sinensis, the Acer truncatum seed oil has a good effect of improving the treatment of Alzheimer's disease, and has a significant improvement effect compared with the use of only Acer truncatum seed oil or the Chinese medicine raw material. Therefore, the present invention further requests protection for the use of a traditional Chinese medicine composition in the preparation of a synergistic Alzheimer's disease drug, wherein the traditional Chinese medicine raw materials in the traditional Chinese medicine composition are composed of 6-9 parts of Gastrodia elata, 8-10 parts of Pueraria lobata, 5-8 parts of Ginseng, 5-9 parts of Poria cocos, 5-9 parts of Lilium, and 6-9 parts of Angelica sinensis, in parts by weight; the traditional Chinese medicine composition improves the therapeutic effect of Acer truncatum seed oil in Alzheimer's disease; the therapeutic effect is to improve at least one of the following: hippocampus, cortical atrophy, spatial learning, memory ability, cognitive dysfunction, antioxidant ability, and intestinal flora diversity.
[0022] Compared with the prior art, the technical solution provided by the present invention has at least the following beneficial effects or advantages.
[0023] Acer truncatum is a deciduous tree, and its seeds are rich in oil, with multiple physiological activities such as anti-oxidation, anti-inflammatory, hypoglycemic, and prevention and treatment of multiple sclerosis. After testing, when Acer truncatum seed oil is used for the prevention and treatment of Alzheimer's disease, its improvement effect is not prominent relative to commercially available drugs, and it is difficult to carry out commercial transformation. To this end, the present invention provides a Chinese medicine raw material composed of Gastrodia elata, Pueraria lobata, ginseng, Poria cocos, Lilium and Angelica sinensis in a specific proportion, which can significantly improve the therapeutic effect of Acer truncatum seed oil when used for the prevention and treatment of Alzheimer's disease, and plays an important role in improving the brain hippocampus, cortical atrophy, spatial learning, memory ability, cognitive dysfunction, antioxidant capacity, intestinal flora diversity and other indicators of Alzheimer's disease mouse model.
[0024] In the microcapsule powder composition containing Acer truncatum seed oil provided by the present invention, the effective ingredients used are composed of Acer truncatum seed oil microcapsule powder and Chinese medicine microcapsule powder. Acer truncatum seed oil microcapsule powder is a microcapsule powder dosage form of Acer truncatum seed oil, which is used to improve the stability, solubility and absorption rate of Acer truncatum seed oil, so that it has good fluidity as a medicine, is easy to disperse and dissolve, and is convenient to take. Chinese medicine microcapsule powder is a Chinese medicine composed of Gastrodia elata, Pueraria lobata, Ginseng, Poria cocos, Lilium, and Angelica sinensis as Chinese medicine raw materials, which is concentrated after water extraction and / or alcohol extraction to obtain a Chinese medicine extract to prepare a microcapsule powder dosage form, which has the function of retaining the original components and properties of the medicine, which will not be lost or changed due to processing; improving the solubility and absorption rate of the medicine, making it easier to be absorbed and utilized by the human body; reducing the volume and weight of the medicine, making it easier to store and carry; simplifying the way of taking the medicine, only need to be taken with water, without decocting or brewing; reducing the taste and smell of the medicine, making it more suitable for patients with sensitive taste. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] In order to more clearly illustrate the technical solution of the present invention, the drawings involved in the description of the embodiments will be briefly introduced below. Obviously, the drawings in the description are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0026] Figure 1 The results of the hippocampus and cortex atrophy test in Alzheimer's disease model mice under different treatments; A is the weight of the hippocampus of the mice under different treatments; B is the weight of the cortex of the mice under different treatments.
[0027] Figure 2 The results of the spatial learning and memory test of Alzheimer's disease model mice under different treatments. A is a schematic diagram of the test device; B is the change in the escape latency of mice under different treatments; C is the target area movement distance of mice under different treatments; D is the target area residence time of mice under different treatments; E is the number of times mice enter the target area under different treatments.
[0028] Figure 3 The results of the cognitive dysfunction test of Alzheimer's disease model mice under different treatments. A is a schematic diagram of the test device; B is the movement distance of the mice in the open arms under different treatments; C is the movement time of the mice in the open arms under different treatments; D is the number of entries into the open arms of the mice under different treatments.
[0029] Figure 4 This is the result of the antioxidant capacity test on Alzheimer's disease model mice under different treatments.
[0030] Figure 5 The results of the intestinal flora diversity test of Alzheimer's disease model mice under different treatments. A is the Chaol richness index; B is the Shannon diversity index.
[0031] In the above figure, express p <0.05, express p <0.01, express p <0.001, ns p >0.05. DETAILED DESCRIPTION
[0032] The technical scheme of the present invention is described below in conjunction with the examples, but the present invention is not limited to the following examples. The experimental methods and detection methods described in each example are conventional methods unless otherwise specified; the reagents and materials are commercially available unless otherwise specified. The "%" indicates mass percentage unless otherwise specified.
[0033] The Acer truncatum seed oil involved in the embodiment of the present invention was purchased from Shandong Fengzhishen Biotechnology Co., Ltd., and the traditional Chinese medicine was purchased from Beijing Tongrentang Co., Ltd.
[0034] Example 1
[0035] This embodiment provides the preparation of Acer truncatum seed oil microcapsule powder.
[0036] This embodiment adopts the emulsification method to prepare the Acer truncatum seed oil microcapsule powder, and the specific steps are as follows:
[0037] (1) Acer truncatum seed oil and emulsifier lecithin were mixed in a mass ratio of 500:20 (test example 1 was adjusted in the range of 500:20 to 50), homogenized with a high-speed homogenizer at 57°C and 15,000 r / min for 10 min, and homogenized three times at 30 MPa for 10 min each time to form an emulsion;
[0038] (2) At 57°C, the emulsion in step (1) and the wall material maltodextrin were mixed in a mass ratio of 6:1 (adjusted in the range of 6:1 to 3 in Test Example 1), stirred at 13,000 r / min for 12 minutes with a stirrer, and homogenized at 30 MPa for 3 times, each time for 8 minutes, to form an emulsion;
[0039] (3) The emulsion in step (2) is spray dried in a spray drying tower at a temperature of 165° C. to obtain Acer truncatum seed oil microcapsule powder.
[0040] Example 2
[0041] This embodiment provides the preparation of Chinese medicine microcapsule powder.
[0042] The specific steps of preparing the microcapsule powder of traditional Chinese medicine in this embodiment are as follows:
[0043] (1) Take 6 parts of Gastrodia elata, 8 parts of Pueraria root, 5 parts of ginseng, 5 parts of Poria cocos, 5 parts of lily, and 6 parts of Angelica sinensis (the range of Test Example 1 is adjusted with reference to 6-9 parts of Gastrodia elata, 8-10 parts of Pueraria root, 5-8 parts of ginseng, 5-9 parts of Poria cocos, 5-9 parts of lily, and 6-9 parts of Angelica sinensis), mix them, and soak them in 9 times the volume of 80% ethanol, heat and reflux for 1 hour, repeat the extraction 3 times, collect the alcohol extract and drug residue after extraction, and concentrate the alcohol extract at 75°C at a ratio of 1.06-1.12 to obtain an alcohol extract concentrate.
[0044] (2) Add 8 times the volume of pure water to the alcohol-extracted drug residue in step (1), heat and reflux for 2 hours, repeat the extraction 3 times, collect the aqueous solution after extraction, and concentrate the aqueous extract at 90° C. at a ratio of 1.05 to 1.12 to obtain an aqueous extract concentrate.
[0045] (3) The alcohol extract concentrate in step (1) and the water extract concentrate in step (2) are mixed and evaporated at 75° C. to obtain a crude extract of Chinese medicine.
[0046] (4) The crude extract of the Chinese medicine in step (3) was dissolved in water at a ratio of 10 g / 100 mL (test example 1 was adjusted in the range of 10 to 30 g:100 mL), and the wall material maltodextrin was added in a mass ratio of 5:1 (test example 1 was adjusted in the range of 5:1 to 3), and stirred with a stirrer at 13,000 r / min for 12 min. Homogenized at 30 MPa for 3 times, each time for 8 min, to form an emulsion.
[0047] (5) At 165° C., the emulsion in step (4) is spray dried through a spray drying tower to obtain a Chinese medicine microcapsule powder.
[0048] Test Example 1
[0049] This test example provides performance tests of Acer truncatum seed oil microcapsule powder and Chinese medicine microcapsule powder under different preparation conditions.
[0050] Referring to Example 1, the parameters of each step were adjusted to obtain a maple seed oil microcapsule powder with an average particle size of 30-40 μm. Referring to Example 2, the parameters of each step were adjusted to obtain a Chinese medicine microcapsule powder with an average particle size of 6-11 μm. The maple seed oil microcapsule powder and Chinese medicine microcapsule powder with different particle sizes were tested, and the test results are shown in Table 1.
[0051] Table 1. Performance test of Acer truncatum seed oil microcapsule powder and Chinese medicine microcapsule powder at different particle sizes
[0052]
[0053] The average particle size of the Acer truncatum seed oil microcapsule powder prepared in Example 1 is 10-20 μm, and the average particle size of the Chinese medicine microcapsule powder prepared in Example 2 is 3-7 μm. As shown in Table 1, by adjusting the various parameters in the preparation steps of the Acer truncatum seed oil microcapsule powder and the Chinese medicine microcapsule powder, the particle size has the greatest influence. When the average particle size of the Acer truncatum seed oil microcapsule powder prepared is 10-20 μm and the average particle size of the Chinese medicine microcapsule powder is 3-7 μm, it has the best drug performance; when the average particle size of the Acer truncatum seed oil microcapsule powder prepared is 10-40 μm and the average particle size of the Chinese medicine microcapsule powder is 3-11 μm, it is within the range that can be barely used in this field. When the particle size range is exceeded, the performance is poor.
[0054] Test Example 2
[0055] This test example provides the therapeutic effect of a microcapsule powder composition containing Acer truncatum seed oil on Alzheimer's disease model mice.
[0056] The microcapsule powder composition containing Acer truncatum seed oil used in this example was prepared by mixing the Acer truncatum seed oil microcapsule powder prepared in Example 1 and the Chinese medicine microcapsule powder prepared in Example 2 at a mass ratio of 4:6. The test group of the microcapsule powder composition containing Acer truncatum seed oil was marked as the AD+ASO group, and the single-dose test group of Acer truncatum seed oil microcapsule powder was marked as the AD group.
[0057] The 5×FAD model mouse was used as an Alzheimer's disease pathological model for the experiment. The 5×FAD mouse expresses human APP and PSEN1 transgenes, with a total of 5 AD-related mutations: Swedish (K670N / M671L), Florida (I716V), and London (V717I) familial Alzheimer's disease (FAD) mutations in APP, and human PS1 overexpression mutant human amyloid beta (A4) precursor protein 695 (APP) carrying 2 FAD mutations M146L and L286V. Animal models related to Alzheimer's disease are very important for the study of disease mechanisms and related drug development. This transgenic mouse model is a commonly used experimental animal model for studying Alzheimer's disease models.
[0058] Twenty one-month-old male 5×FAD transgenic Alzheimer's disease model mice were randomly divided into two groups, AD group and AD+ASO group, with 10 mice in each group. In addition, 10 one-month-old male C57BL / 6 J mice were randomly selected as wild-type normal control group (WT group). The WT group mice were fed with standard mouse feed, the AD group was fed with mouse feed containing the Acer truncatum seed oil microcapsule powder prepared in Example 1, and the AD+ASO group was fed with mouse feed containing the microcapsule powder composition, with an admixture amount of 5%, and continued to be fed until 6 months of age.
[0059] After the feeding, the therapeutic effect of the microcapsule powder composition on Alzheimer's disease model mice was tested. The test results are as follows: Figures 1 to 5 shown.
[0060] Figure 1 It shows that feeding Alzheimer's model mice with a Chinese medicine composition microcapsule powder containing Acer truncatum seed oil improved the atrophy of the hippocampus and cortex of the Alzheimer's model mice. This shows that the Chinese medicine composition microcapsule powder containing Acer truncatum seed oil can improve the weight loss of the hippocampus and cortex of the Alzheimer's model mice.
[0061] Figure 2 The results showed that in the Barnes maze test, after the Alzheimer's model mice were fed with the microcapsule powder of the Chinese medicine composition containing Acer truncatum seed oil, the movement distance, residence time and number of entries in the quadrant where the target hole was located increased, and the residence time increased significantly. The results showed that the microcapsule powder of the Chinese medicine composition containing Acer truncatum seed oil improved the spatial learning and memory ability of the Alzheimer's model mice.
[0062] Figure 3 The results showed that in the elevated plus maze experiment, after the Alzheimer's disease model mice were fed with the microcapsule powder of the Chinese medicine composition containing Acer truncatum seed oil, the movement distance, activity time and number of entries in the open arm were reduced, among which the movement distance and number of entries were significantly shortened. These results indicate that the microcapsule powder of the Chinese medicine composition containing Acer truncatum seed oil can improve the cognitive dysfunction of mice.
[0063] GSH-Px is an important antioxidant enzyme in the body, and its activity can reflect the body's antioxidant capacity. Figure 4 It showed that after Alzheimer's disease model mice were fed with microcapsule powder of a Chinese medicine composition containing Acer truncatum seed oil, the antioxidant capacity of the mice was significantly improved.
[0064] Alpha diversity refers to the diversity within a specific area or ecosystem, and is a comprehensive indicator reflecting richness and uniformity. Alpha diversity is mainly related to two factors: one is the number of species, that is, richness; the other is diversity, that is, the uniformity of individual distribution in the community. The QIIME2 software was used for calculation and analysis, in which the Chao1 richness index reflects the richness of the intestinal flora. The larger the value, the higher the richness of the community. The Shannon diversity index reflects the diversity of the intestinal flora. The larger the value, the higher the diversity of the community. Figure 5 It showed that after Alzheimer's disease model mice were fed with microcapsule powder of a Chinese medicine composition containing Acer truncatum seed oil, the richness and diversity of the mice's intestinal flora were improved, which played a positive regulatory role on the intestinal flora.
[0065] After testing, the ratio of the Acer truncatum seed oil microcapsule powder to the Chinese medicine microcapsule powder is (4-8):6 by mass ratio; the Chinese medicine extract is mixed with water at a ratio of 10-30 g:100 mL.
[0066] The particle size of the Acer truncatum seed oil microcapsule powder is 10-40 μm, and the particle size of the Chinese medicine microcapsule powder is 3-11 μm; in terms of weight, the Chinese medicine raw materials in the Chinese medicine composition are composed of 6-9 parts of Gastrodia elata, 8-10 parts of Pueraria root, 5-8 parts of Ginseng, 5-9 parts of Poria cocos, 5-9 parts of Lilium, and 6-9 parts of Angelica sinensis; when the amount of mouse feed added is 2-8%, within the scope of the technical solution provided by the present invention, it has a good therapeutic effect on Alzheimer's disease model mice, and is better than a single dose of Acer truncatum seed oil microcapsule powder or Chinese medicine microcapsule powder. The above embodiments and test examples are only the optimal ratio and implementation examples.
[0067] The embodiments described above are part of the embodiments of the present invention, but not all of them. The detailed description of the embodiments of the present invention is not intended to limit the scope of the invention claimed for protection, but only represents selected embodiments of the present invention. All other embodiments obtained without creative work and related deductions and substitutions made by ordinary technicians in the field under the conditions of the concept of the present invention belong to the scope of protection of the present invention.
Claims
1. A microcapsule powder composition containing Acer truncatum seed oil, characterized in that: It is composed of Acer truncatum seed oil microcapsule powder and Chinese medicine microcapsule powder; In parts by weight, the Chinese medicine raw materials in the Chinese medicine microcapsule powder are composed of 6-9 parts of Gastrodia elata, 8-10 parts of Pueraria root, 5-8 parts of ginseng, 5-9 parts of Poria cocos, 5-9 parts of lily, and 6-9 parts of Angelica sinensis; In terms of mass ratio, the ratio of the Acer truncatum seed oil microcapsule powder to the Chinese medicine microcapsule powder is (4-8):6; The particle size of the Acer truncatum seed oil microcapsule powder is 10-40 μm, and the particle size of the traditional Chinese medicine microcapsule powder is 3-11 μm.
2. The microcapsule powder composition containing Acer truncatum seed oil according to claim 1, characterized in that: Calculated by mass ratio, the ratio of the Acer truncatum seed oil microcapsule powder to the Chinese medicine microcapsule powder is 4:
6.
3. The microcapsule powder composition containing Acer truncatum seed oil according to claim 1, characterized in that: In parts by weight, the Chinese medicinal raw materials in the Chinese medicinal microcapsule powder are composed of 6 parts of Gastrodia elata, 8 parts of Pueraria root, 5 parts of ginseng, 5 parts of Poria cocos, 5 parts of lily, and 6 parts of Angelica sinensis.
4. The method for preparing the microcapsule powder composition containing Acer truncatum seed oil according to any one of claims 1 to 3, characterized in that: include: The Acer truncatum seed oil is emulsified and then embedded with a wall material to prepare the Acer truncatum seed oil microcapsule powder; The Chinese medicine raw material is extracted with water and / or alcohol and then concentrated to obtain a Chinese medicine extract. The Chinese medicine extract is mixed with water and embedded with a wall material to obtain the Chinese medicine microcapsule powder.
5. The method for preparing the microcapsule powder composition containing Acer truncatum seed oil according to claim 4, characterized in that: The emulsifier used in the emulsification is lecithin; The wall material used in the Acer truncatum seed oil microcapsule powder and / or the Chinese medicine microcapsule powder is maltodextrin.
6. The method for preparing the microcapsule powder composition containing Acer truncatum seed oil according to claim 4, characterized in that: The Chinese herbal medicine extract is mixed with water in a ratio of 10-30 g:100 mL.
7. Use of the microcapsule powder composition containing Acer truncatum seed oil according to any one of claims 1 to 3 in the preparation of a drug for Alzheimer's disease, characterized in that: The microcapsule powder composition containing Acer truncatum seed oil improves at least one of the following: atrophy of the hippocampus and cortex, spatial learning, memory ability, cognitive dysfunction, antioxidant capacity, and intestinal flora diversity.
8. Use of a Chinese medicine composition in the preparation of a drug for enhancing Alzheimer's disease, characterized in that: In parts by weight, the Chinese medicinal raw materials in the Chinese medicinal composition are composed of 6-9 parts of Gastrodia elata, 8-10 parts of Pueraria root, 5-8 parts of ginseng, 5-9 parts of Poria cocos, 5-9 parts of lily, and 6-9 parts of Angelica sinensis; The Chinese medicine composition improves the therapeutic effect of Acer truncatum seed oil on Alzheimer's disease; The therapeutic effect is to improve at least one of cognitive dysfunction, antioxidant capacity, and intestinal flora diversity.
